Embecta Corp. (EMBC) Stock Score, Valuation & Financial Research
Embecta Corp. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 48/100.
Quick answer for EMBC
Embecta Corp. currently has a Wall Street Score of 48/100. The stored market price is $4.94. Its financial score is 23/100. Its valuation score is 100/100. These figures are a research snapshot, not a buy or sell recommendation.
What Embecta Corp. does
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
EMBC financial snapshot
- Wall Street Score:
- 48/100
- Current price:
- $4.94
- Market capitalization:
- $293.1M
- Revenue:
- $1.02B
- Net income:
- $87.5M
- Free cash flow:
- $182.4M
- Cash:
- $214.7M
- Total debt:
- $1.50B
- EPS:
- 1.49
- P/E ratio:
- 3.3x
- Financial score:
- 23/100
- Valuation score:
- 100/100
- Revenue score:
- 38/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $182.4M, showing positive cash generation.
- The balance sheet shows $214.7M of cash versus $1.50B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 23/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research EMBC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.